Luminoma Diagnostics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 3

Luminoma Diagnostics General Information

Description

Developer of a portable, laser-based diagnostic device intended to objectively screen skin lesions for cancer. The company uses Raman spectroscopy and machine learning technology, enabling clinicians to quickly and non-invasively assess whether a skin lesion is likely malignant or benign, with the goal of reducing unnecessary biopsies while improving early cancer detection.

Contact Information

Website
www.luminomadx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Suite 1, Level 18
  • 125 Queen Street
  • Auckland, 1010
  • New Zealand
Primary Industry
Diagnostic Equipment
Vertical(s)
Manufacturing, HealthTech
Corporate Office
  • Suite 1, Level 18
  • 125 Queen Street
  • Auckland, 1010
  • New Zealand

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Luminoma Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 18-Nov-2024 Completed Stealth
2. Early Stage VC Completed Stealth
1. Accelerator/Incubator 11-Dec-2023 Completed Stealth
To view Luminoma Diagnostics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Luminoma Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Luminoma Diagnostics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Pacific Channel Venture Capital Minority
Bridgewest Ventures Accelerator/Incubator Minority
Auckland UniServices Corporate Venture Capital Minority
To view Luminoma Diagnostics’s complete investors history, request access »

Ready to get started?

Request a free trial

Luminoma Diagnostics FAQs

  • When was Luminoma Diagnostics founded?

    Luminoma Diagnostics was founded in 2023.

  • Where is Luminoma Diagnostics headquartered?

    Luminoma Diagnostics is headquartered in Auckland, New Zealand.

  • What is the size of Luminoma Diagnostics?

    Luminoma Diagnostics has 5 total employees.

  • What industry is Luminoma Diagnostics in?

    Luminoma Diagnostics’s primary industry is Diagnostic Equipment.

  • Is Luminoma Diagnostics a private or public company?

    Luminoma Diagnostics is a Private company.

  • What is Luminoma Diagnostics’s current revenue?

    The current revenue for Luminoma Diagnostics is .

  • Who are Luminoma Diagnostics’s investors?

    Pacific Channel, Bridgewest Ventures, and Auckland UniServices have invested in Luminoma Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »